Kakao Mobility submits application for US IPO
Kakao Mobility Corporation, a South Korean ride-hailing and connected technologies company, has submitted an application to launch an…
SK Hynix Just Raised $26.5 Billion in the Biggest U.S. IPO Ever by a Foreign Company. Here’s What It Signals for the AI Memory Boom.
The biggest U.S. initial public offering (IPO) ever by a foreign company belongs to a memory-chip maker. South…
How to Play SKHY Stock Following the SK Hynix IPO
All eyes are on the South Korean semiconductor powerhouse, SK Hynix (SKHY), this morning as it makes a highly…
SK Hynix raises $26.5B in the biggest foreign IPO in US history, is urged to build new US fabs
The AI chip boom just produced its biggest Wall Street moment yet. SK Hynix, a South Korean memory…
Chip giant SK Hynix raises $26.5 billion in blockbuster US share offering
SK Hynix (000660.KS) has raised $26.5 billion in its Wall Street share offering, marking the biggest first-time listing…
SK Hynix IPO to give US investors bigger bite of the memory pie, as shortages persist
SK Hynix will make its US public trading debut on the Nasdaq on Friday. The initial public offering…
SK Hynix’s $28 Billion Nasdaq Listing Would Be the Second-Biggest Share Sale Ever. Here’s What Investors Should Know.
One of the most important companies in the artificial intelligence (AI) supply chain is about to become far…
SKHY IPO News – Korea-listed memory chip giant SK hynix sets terms for $28.1 billion US IPO, pricing this week
SK hynix, which is a leading South Korea-based DRAM and flash memory chip maker, announced terms for…
SKHY IPO News – Korea-listed memory chip giant SK hynix files for an estimated $29 billion US IPO
SK hynix, a leading South Korea-based DRAM and flash memory chip maker, filed on Wednesday with the…
Failed SpaceX IPO allocation prompts Korea to widen Mirae review
South Korea’s financial watchdog has expanded an inspection of Mirae Asset Securities Co. to examine the brokerage’s failure…
Ingenia Therapeutics, a Clinical-Stage Biotechnology Company, Has Received Approval for an Initial Public Offering on the Korea Exchange (KRX)
WATERTOWN, Mass., May 21, 2026–(BUSINESS WIRE)–Ingenia Therapeutics, a clinical-stage biotechnology company pioneering next-generation vascular-targeted therapies, announced that the…